Champions Oncology, Inc. Banner Image

Champions Oncology, Inc.

  • Ticker CSBR
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Champions Oncology, Inc. Logo Image
  • 51-200 Employees
  • Based in Hackensack, New Jersey
Champions Oncology, Inc. is engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs. The Company's technology platform is a novel approach to personalizing cancer care based upon the implantation of primary human tumors in immune deficient mice followed by propagation of the resulting engraftments, or Champions TumorGraftsMore, in a manner that preserves the biological characteristics of the original human tumor in order to determine the efficacy of a treatment regimen. The Company uses this technology in conjunction with related services to offer solutions for pharmaceutical and biotechnology companies seeking personalized approaches to drug development that can lower the cost and increase the speed of developing new drugs. TumorGrafts are procured through agreements with a number of institutions in the U.S. and overseas as well as through Champions' Personalized Oncology Solutions business, in which results help guide the development of personalized treatment plans for individual patients.
4.8 / 5.0 (152)

Champions Oncology, Inc. reports have an aggregate usefulness score of 4.8 based on 152 reviews.

Champions Oncology, Inc.

Most Recent Annual Report

Champions Oncology, Inc.
MOST RECENT 2023 Annual Report and Form 10K

Older/Archived Annual Reports

Champions Oncology, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!